reboxetine has been researched along with triiodothyronine in 2 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 26,247 | 861 | 3,473 |
| Protein | Taxonomy | reboxetine (IC50) | triiodothyronine (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
| Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fava, M | 1 |
| Cohen, A; Cooper-Kazaz, R; Lerer, B | 1 |
1 review(s) available for reboxetine and triiodothyronine
| Article | Year |
|---|---|
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
1 other study(ies) available for reboxetine and triiodothyronine
| Article | Year |
|---|---|
Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.
Topics: Adult; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Reboxetine; Sleep Wake Disorders; Triiodothyronine; Young Adult | 2010 |